Related Experiment Videos
[Extrarenal dialysis in end-stage renal disease]
B Canaud1, H Leray-Moragues, A Slingeneyer
1Service de néphrologie, CHU Montpellier, hôpital Lapeyronie, 34295 Montpellier. b-canaud@chu-montpellier.fr
La Revue Du Praticien
|May 18, 2001
Summary
Renal replacement therapy (RRT) effectively treats end-stage renal failure (ESRF) using various methods. However, long-term dialysis presents new challenges and requires a revised RRT approach for optimal patient outcomes.
Area of Science:
- Nephrology
- Internal Medicine
Context:
- Renal replacement therapy (RRT) is a mature treatment for end-stage renal failure (ESRF).
- Current RRT modalities include hemodialysis and peritoneal dialysis, ensuring life support.
- Substitution of renal endocrine functions with human recombinant erythropoietin and active vitamin D has improved ESRF patient quality of life.
Purpose:
- To review the current state of RRT for ESRF.
- To highlight the emergence of long-term dialysis-related pathologies as a significant challenge.
- To advocate for a revised RRT concept and comprehensive management strategies.
Summary:
- RRT, encompassing hemodialysis and peritoneal dialysis, is essential for ESRF management.
- While effective, long-term RRT leads to specific pathologies, posing a challenge for nephrologists.
- Optimal ESRF treatment requires a multifaceted approach, including potential renal transplantation.
Impact:
- RRT significantly improves the quality of life for ESRF patients.
- Identifying and addressing long-term dialysis-related pathologies is crucial for future nephrology practice.
- A revised RRT concept and integrated management are necessary for optimal long-term outcomes in ESRF.